ARTICLE | Clinical News
GlycoPEGylated Factor VIIa regulatory update
April 21, 2008 7:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued positive opinions to grant Orphan Drug designation for Novo's GlycoPEGylated factor VIIa to treat hemophilia A and B. The pegylated formula...